PCTC
AZN icon

Perkins Coie Trust Company’s AstraZeneca AZN Stock Holding History

Perkins Coie Trust Company’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3
Closed -$441 – 298
2025
Q1 		$441 Buy
+3
New +$434 ﹤0.01% 352
2023
Q4 		– Sell
-20
Closed -$2.64K – 321
2023
Q3 		$2.64K Buy
+20
New +$2.73K ﹤0.01% 322

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Perkins Coie Trust Company's AZN Position: Q2 2025 in Review

Perkins Coie Trust Company sold out of AstraZeneca (AZN) in Q2 2025, closing a stake of 3 shares — an estimated $441 sold.

Perkins Coie Trust Company first reported a position in AZN in Q3 2023 and held it in 2 quarters. The position peaked at $2.64K in Q3 2023. 1,222 funds tracked by Wall St. Rank hold AZN as of Q2 2025.

  • Perkins Coie Trust Company reported no remaining AstraZeneca position as of Q2 2025 after selling out during the quarter.
  • Perkins Coie Trust Company sold 3 AstraZeneca shares in Q2 2025, an estimated $441.
  • Perkins Coie Trust Company first reported a position in AstraZeneca in Q3 2023 and held it in 2 quarters.
  • Perkins Coie Trust Company's AstraZeneca position peaked at $2.64K in Q3 2023.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2025.

Based on Perkins Coie Trust Company's 13F filing for Q2 2025, filed 10 Jul 2025.